Rising Prevalence Of Asthma Fuels Growth In The Montelukast Sodium Market Is Supporting Development Across The Montelukast Sodium Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Size Of The Montelukast Sodium Market Progress Through 2030?

The montelukast sodium market size has seen robust growth over recent years. It is anticipated to expand from $4.2 billion in 2025 to $4.59 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. The drivers for this historic period’s growth include the extensive clinical application of montelukast in asthma management, the increasing occurrence of allergic respiratory ailments, its demonstrated safety profile in prolonged treatment, widespread physician acceptance for maintenance therapy, and the availability of economical generic versions.

The montelukast sodium market size is projected to experience robust expansion over the coming years. It is forecasted to reach $6.33 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This growth during the forecast period is attributable to an increasing global prevalence of asthma and allergic rhinitis, higher diagnosis rates for pediatric asthma, greater understanding of non-steroidal asthma treatments, wider availability of respiratory medications in developing regions, and sustained need for oral maintenance medications. Key trends anticipated for this period include an escalating demand for leukotriene receptor antagonists in managing asthma, expanded application of montelukast in treating allergic rhinitis, a rise in generic montelukast sodium formulations, a preference for oral solid dosage forms for chronic respiratory conditions, and an increase in prescriptions for both pediatric and adult asthma patients.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

What Market Drivers Are Helping Shape The Montelukast Sodium Market Expansion?

The expanding occurrence of asthma is projected to fuel the advancement of the montelukast sodium market in the future. Asthma is a persistent respiratory ailment characterized by inflammation and narrowing of the airways, leading to recurrent episodes of wheezing, shortness of breath, chest constriction, and coughing. The rising incidence of asthma is attributable to factors such as environmental pollution, exposure to allergens, genetic susceptibility, urbanization, shifts in lifestyle, and respiratory infections. Montelukast sodium functions as a leukotriene receptor antagonist in asthma treatment, aiding in the prevention and control of asthma symptoms by inhibiting the activity of leukotrienes, which contribute to airway inflammation and constriction. For example, in October 2024, data from the National Asthma Council, an Australia-based non-profit organization, indicated that in 2023, Australia registered a total of 474 asthma-related deaths, consisting of 325 females and 149 males. This total is nearly the same as the 473 asthma-related deaths documented in 2022, showing a steady pattern in asthma fatalities across both years. Consequently, the increasing prevalence of asthma is stimulating the growth of the montelukast sodium market.

Which Segment-Based Categories Are Covered In The Montelukast Sodium Market?

The montelukast sodium market covered in this report is segmented –

1) By Product: Crystal-like, Form-less Or Amorphous

2) By Dosage Form: Tablets, Oral Solutions

3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Subsegments:

1) By Crystal-Like: Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium

2) By Form-Less Or Amorphous: Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

Which Trends Are Supporting The Evolution Of The Montelukast Sodium Market?

Leading companies in the montelukast sodium market are concentrating on developing creative solutions, such as combination therapies, to offer more extensive allergy and asthma relief and improve patient adherence. Combination therapies are treatments that utilize two or more drugs together in a single regimen to target multiple disease pathways for enhanced efficacy. For example, in October 2025, Cadila Pharmaceuticals Ltd., an India-based pharmaceutical company, launched Dlorfast-M tablets, a fixed-dose combination therapy containing desloratadine (5 mg) and montelukast (10 mg) for the management of allergic rhinitis and urticaria. It delivers broad symptom control by targeting both histamine and leukotriene pathways in a convenient once-daily oral dosage. This innovative formulation aims to enhance patient compliance and provide long-term relief with good tolerability.

Which Companies Form The Competitive Landscape Of The Montelukast Sodium Market?

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Access The Complete Montelukast Sodium Market Report:

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Which Region Commands The Largest Share Of The Montelukast Sodium Market?

North America was the largest region in the montelukast sodium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Montelukast Sodium Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

Browse Through More Reports Similar to the Global Montelukast Sodium Market 2026, By The Business Research Company

Montelukast Sodium Market Report 2026

https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Sodium Reduction Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/sodium-reduction-ingredients-global-market-report

Sodium Benzoate Market Report 2026

https://www.thebusinessresearchcompany.com/report/sodium-benzoate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795